Advertisement

Drugs & Therapy Perspectives

, Volume 34, Issue 7, pp 311–315 | Cite as

Manage osteoporotic pain by treating osteoporosis and taking a multidimensional approach to pain management

  • Adis Medical Writers
Disease Management
  • 72 Downloads

Abstract

Although osteoporosis is referred as a silent disease due to its asymptomatic nature, many patients experience pain from osteoporosis-related fractures. Adequate pain management and osteoporosis treatment are necessary to improve patients’ health-related quality of life. Nonpharmacological (e.g. physical exercise, physiotherapy) and pharmacological (e.g. analgesics, antiresorptive agents) interventions are used to reduce fracture risk and manage pain.

Notes

Compliance with ethical standards

Conflict of interest

The article was adapted from Drugs & Aging 2017;34(10):755–65 [1] by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.

Funding

The preparation of this review was not supported by any external funding.

References

  1. 1.
    Catalano A, Martino G, Morabito N, et al. Pain in osteoporosis: from pathophysiology to therapeutic approach. Drugs Aging. 2017;34(10):755–65.CrossRefPubMedGoogle Scholar
  2. 2.
    O’Neill TW, Felsenberg D, Varlow J, et al. The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res. 1996;11(7):1010–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Kaptoge S, Armbrecht G, Felsenberg D, et al. When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res. 2004;19(12):1982–93.CrossRefPubMedGoogle Scholar
  4. 4.
    Pinto-Ribeiro F, Moreira V, Pego JM, et al. Antinociception induced by chronic glucocorticoid treatment is correlated to local modulation of spinal neurotransmitter content. Mol Pain. 2009;5:41.  https://doi.org/10.1186/1744-8069-5-41.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Lange U, Teichmann J, Uhlemann C. Current knowledge about physiotherapeutic strategies in osteoporosis prevention and treatment. Rheumatol Int. 2005;26(2):99–106.CrossRefPubMedGoogle Scholar
  6. 6.
    McCarthy J, Davis A. Diagnosis and management of vertebral compression fractures. Am Fam Phys. 2016;94(1):44–50.Google Scholar
  7. 7.
    Angin E, Erden Z, Can F. The effects of clinical pilates exercises on bone mineral density, physical performance and quality of life of women with postmenopausal osteoporosis. J Back Musculoskelet Rehabil. 2015;28(4):849–58.CrossRefPubMedGoogle Scholar
  8. 8.
    Lee CH, Lee TY, Her JS, et al. Single-blinded, randomized preliminary study evaluating the effect of transcutaneous electrical nerve stimulation on postoperative pain in patients with Colles’ fracture. J Altern Complement Med. 2015;21(12):754–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Bautmans I, Van Arken J, Van Mackelenberg M, et al. Rehabilitation using manual mobilization for thoracic kyphosis in elderly postmenopausal patients with osteoporosis. J Rehabil Med. 2010;42(2):129–35.CrossRefPubMedGoogle Scholar
  10. 10.
    Iwamoto J, Takeda T, Sato Y, et al. Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate. Aging Clin Exp Res. 2005;17(2):157–63.CrossRefPubMedGoogle Scholar
  11. 11.
    Mert T, Kurt AH, Altun I, et al. Pulsed magnetic field enhances therapeutic efficiency of mesenchymal stem cells in chronic neuropathic pain model. Bioelectromagnetics. 2017;38(4):255–64.CrossRefPubMedGoogle Scholar
  12. 12.
    Bistolfi F. Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis. Neuroradiol J. 2007;20(6):676–93.CrossRefPubMedGoogle Scholar
  13. 13.
    Maestu C, Blanco M, Nevado A, et al. Reduction of pain thresholds in fibromyalgia after very low-intensity magnetic stimulation: a double-blinded, randomized placebo-controlled clinical trial. Pain Res Manag. 2013;18(6):e101–6.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Schiller J, Korallus C, Bethge M, et al. Effects of acupuncture on quality of life and pain in patients with osteoporosis—a pilot randomized controlled trial. Arch Osteoporos. 2016;11(1):34.  https://doi.org/10.1007/s11657-016-0288-x.CrossRefPubMedGoogle Scholar
  15. 15.
    Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol. 2014;69(2):153–66.CrossRefPubMedGoogle Scholar
  16. 16.
    Bauer DC, Orwoll ES, Fox KM, Study of Osteoporotic Fractures Research Group, et al. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. J Bone Miner Res. 1996;11(1):29–35.CrossRefPubMedGoogle Scholar
  17. 17.
    Vellucci R, Mattia C, Celidonio L, et al. Implications of analgesics use in osteoporotic-related pain treatment: focus on opioids. Clin Cases Miner Bone Metab. 2016;13(2):89–92.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Kim S, Seiryu M, Okada S, et al. Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone. Eur J Pharmacol. 2013;699(1–3):14–22.CrossRefPubMedGoogle Scholar
  19. 19.
    O’Connor JP, Lysz T. Celecoxib, NSAIDs and the skeleton. Drugs Today (Barc). 2008;44(9):693–709.CrossRefGoogle Scholar
  20. 20.
    Adolphson P, Abbaszadegan H, Jonsson U, et al. No effects of piroxicam on osteopenia and recovery after Colles’ fracture: a randomized, double-blind, placebo-controlled, prospective trial. Arch Orthop Trauma Surg. 1993;112(3):127–30.CrossRefPubMedGoogle Scholar
  21. 21.
    Davis TR, Ackroyd CE. Non-steroidal anti-inflammatory agents in the management of Colles’ fractures. Br J Clin Pract. 1988;42(5):184–9.PubMedGoogle Scholar
  22. 22.
    Paolucci T, Saraceni VM, Piccinini G. Management of chronic pain in osteoporosis: challenges and solutions. J Pain Res. 2016;9:177–86.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Sheedy KC, Camara MI, Camacho PM. Comparison of the efficacy, adverse effects, and cost of zoledronic acid and denosumab in the treatment of osteoporosis. Endocr Pract. 2015;21(3):275–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Songpatanasilp T, Mumtaz M, Chhabra H, et al. Back pain in patients with severe osteoporosis on teriparatide or antiresorptives: a prospective observational study in a multiethnic population. Singap Med J. 2014;55(9):493–501.CrossRefGoogle Scholar
  25. 25.
    Bruyere O, Delferriere D, Roux C, et al. Effects of strontium ranelate on spinal osteoarthritis progression. Ann Rheum Dis. 2008;67(3):335–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Delmas PD. Clinical effects of strontium ranelate in women with postmenopausal osteoporosis. Osteoporos Int. 2005;16(Suppl 1):S16–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Genant HK, Halse J, Briney WG, et al. The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis. Curr Med Res Opin. 2005;21(7):1027–34.CrossRefPubMedGoogle Scholar
  28. 28.
    Chen LX, Li YL, Ning GZ, et al. Comparative efficacy and tolerability of three treatments in old people with osteoporotic vertebral compression fracture: a network meta-analysis and systematic review. PLoS One. 2015;10(4):e0123153.  https://doi.org/10.1371/journal.pone.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations